Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine–melphalan conditioning for treatment of mature T-cell lymphomas
Maria Delioukina, Jasmine Zain, J M Palmer, et al.
Bone Marrow Transplantation (2011) Vol. 47, Iss. 1, pp. 65-72
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma
Sonali M. Smith, Linda J. Burns, Koen van Besien, et al.
Journal of Clinical Oncology (2013) Vol. 31, Iss. 25, pp. 3100-3109
Open Access | Times Cited: 223
Mycosis Fungoides and Sézary Syndrome
Robert Stuver, Alison J. Moskowitz, Sarah Noor, et al.
(2023), pp. 635-646
Closed Access | Times Cited: 177
Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation
Mohamed A. Kharfan‐Dabaja, Ambuj Kumar, Ernesto Ayala, et al.
Biology of Blood and Marrow Transplantation (2017) Vol. 23, Iss. 11, pp. 1826-1838
Open Access | Times Cited: 144
British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018
D. Gilson, Sean Whittaker, Fiona Child, et al.
British Journal of Dermatology (2018) Vol. 180, Iss. 3, pp. 496-526
Closed Access | Times Cited: 131
Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
Adèle de Masson, M. Beylot‐Barry, C. Ram‐Wolff, et al.
The Lancet (2023) Vol. 401, Iss. 10392, pp. 1941-1950
Open Access | Times Cited: 34
Allogeneic hematopoietic stem cell transplantation for T-cell lymphomas
Norbert Schmitz, Georg Lenz, Matthias Stelljes
Blood (2018) Vol. 132, Iss. 3, pp. 245-253
Closed Access | Times Cited: 61
Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
Anne‐Claire Mamez, Axelle Dupont, Didier Blaise, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 41
Haematopoietic stem cell transplant in cutaneous T‐cell lymphomas: A multicentre propensity‐score matched study
Lía Bejarano, Mercè Grau‐Pérez, Marina Paíno‐Román, et al.
Journal of the European Academy of Dermatology and Venereology (2025)
Closed Access
Efficacy of Allogeneic Hematopoietic Cell Transplantation in Cutaneous T Cell Lymphoma: Results of a Systematic Review and Meta-Analysis
Madiha Iqbal, Tea Reljic, Ernesto Ayala, et al.
Biology of Blood and Marrow Transplantation (2019) Vol. 26, Iss. 1, pp. 76-82
Open Access | Times Cited: 36
Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysis
Amrita Goyal, Daniel E. O’Leary, Francine M. Foss
Bone Marrow Transplantation (2023) Vol. 59, Iss. 1, pp. 41-51
Closed Access | Times Cited: 12
Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas
Vikram R. Paralkar, Sunita D. Nasta, Kathryn Morrissey, et al.
Bone Marrow Transplantation (2011) Vol. 47, Iss. 7, pp. 940-945
Open Access | Times Cited: 35
Comparison of outcomes between autologous and allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphomas with central review of pathology
S-W Kim, S-S Yoon, Ritsuro Suzuki, et al.
Leukemia (2012) Vol. 27, Iss. 6, pp. 1394-1397
Closed Access | Times Cited: 35
Allogeneic Transplantation in T-Cell Lymphomas
Norbert Schmitz, Huei-Shan Wu, Bertram Glaß
Seminars in Hematology (2013) Vol. 51, Iss. 1, pp. 67-72
Closed Access | Times Cited: 20
Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma
Andrew M. Rogers, Jonathan E. Brammer
Current Hematologic Malignancy Reports (2020) Vol. 15, Iss. 4, pp. 316-332
Open Access | Times Cited: 17
Is myeloablative dose intensity necessary in allogeneic hematopoietic cell transplantation for lymphomas?
Mohamed A. Kharfan‐Dabaja, Najla El‐Jurdi, Ernesto Ayala, et al.
Bone Marrow Transplantation (2017) Vol. 52, Iss. 11, pp. 1487-1494
Open Access | Times Cited: 18
Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Monzr M. Al Malki, Nitya Nathwani, Dongyun Yang, et al.
Biology of Blood and Marrow Transplantation (2018) Vol. 24, Iss. 9, pp. 1828-1835
Open Access | Times Cited: 17
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome
Luca Castagna, Thomas Pagliardini, Stéfania Bramanti, et al.
Bone Marrow Transplantation (2020) Vol. 56, Iss. 4, pp. 883-889
Open Access | Times Cited: 13
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source
Cole Sterling, Michael Sang Hughes, Hua‐Ling Tsai, et al.
Transplantation and Cellular Therapy (2022) Vol. 29, Iss. 4, pp. 267.e1-267.e5
Open Access | Times Cited: 8
Allogeneic stem cell transplantation in patients with aggressive primary cutaneous T‐cell lymphoma – a case series of the ADF working group „cutaneous lymphomas”
Rose K. C. Moritz, Markus Ditschkowski, Claus‐Detlev Klemke, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2013) Vol. 12, Iss. 1, pp. 39-46
Closed Access | Times Cited: 14
Diagnosis, prognosis and management of erythrodermic cutaneous T-cell lymphoma
B. Moriarty, Sean Whittaker
Expert Review of Hematology (2014) Vol. 8, Iss. 2, pp. 159-171
Closed Access | Times Cited: 12
Allogeneic stem cell transplantation against aggressive lymphomas: graft-versus-lymphoma effects in peripheral T-cell lymphoma and diffuse large B-cell lymphoma after myeloablative conditioning
Evgenii Shumilov, Lewis J. Levien, Paolo Mazzeo, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-12
Closed Access | Times Cited: 1
Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis
Anna Czyż, Joanna Romejko‐Jarosińska, Grzegorz Helbig, et al.
Annals of Hematology (2013) Vol. 92, Iss. 7, pp. 925-933
Open Access | Times Cited: 11
New developments in the treatment of peripheral T-cell lymphoma – role of Belinostat
Peter Reimer
Cancer Management and Research (2015), pp. 145-145
Open Access | Times Cited: 10
Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
Eva Domingo‐Domènech, Ariane Boumendil, Fina Climent, et al.
Bone Marrow Transplantation (2019) Vol. 55, Iss. 3, pp. 633-640
Open Access | Times Cited: 8
Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma
Chathuri Abeyakoon, Carrie Van Der Weyden, Sean Harrop, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3125-3125
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top